<DOC>
	<DOC>NCT01790841</DOC>
	<brief_summary>The purpose of the study is to proof the safety and efficacy of the new ICD sytem (Iforia/Ilesto). The devices are available with DF-1 and DF4 connection. A special focus is set on the ICD system with DF4 connection.</brief_summary>
	<brief_title>DF4 Master Study (Safety and Efficacy Study)</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Death</mesh_term>
	<mesh_term>Death, Sudden, Cardiac</mesh_term>
	<mesh_term>Tachycardia, Ventricular</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<criteria>Patient has provided written informed consent. Patient has standard ICD/CRTD indication. Patient accepts Home Monitoring concept. Patient is able to attend the planned hospital followup visits. Patient has legal capacity and ability to consent. Patient has a standard contraindication for ICD/CRTD therapy. Age &lt; 18 years Patient is pregnant or breastfeeding. Patient is expected to receive ventricular assist device or heart transplantation within the next 12 months. Life expectancy of less than 12 months. Participating in any other clinical study of an investigational cardiac drug or device.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>